Treatment of Non-Purulent Cellulitis Failing Cephalexin

Initial Management

The Infectious Diseases Society of America recommends adding MRSA-active coverage with either clindamycin 300-450 mg orally three times daily or trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets twice daily, plus continuing a beta-lactam, for patients with non-purulent leg cellulitis who have failed cephalexin therapy, treating for 5 days if clinical improvement occurs 1, 2

The American College of Physicians suggests immediately evaluating for warning signs of necrotizing fasciitis or deeper infection, including severe pain out of proportion to examination findings, skin anesthesia, rapid progression, or gas in tissue, and systemic toxicity, in patients with non-purulent cellulitis who have failed cephalexin therapy 1, 2
Patients with any of these features should obtain emergent surgical consultation immediately and initiate broad-spectrum IV combination therapy with vancomycin 15-20 mg/kg every 8-12 hours plus piperacillin-tazobactam 3.375-4.5 g every 6 hours 1, 2

Clindamycin 300-450 mg orally three times daily is the optimal choice for patients with non-purulent cellulitis who have failed cephalexin therapy, as it provides single-agent coverage for both beta-hemolytic streptococci and MRSA, but only if local MRSA clindamycin resistance rates are <10% 1, 2
For patients with higher MRSA clindamycin resistance rates, combination therapy with TMP-SMX 1-2 double-strength tablets twice daily plus a beta-lactam, such as amoxicillin 500 mg three times daily or continuing cephalexin, is recommended 1, 2

Patients with non-purulent cellulitis who have failed cephalexin therapy should be admitted for IV antibiotics if they show no improvement after 48 hours of appropriate oral MRSA-active therapy, develop systemic inflammatory response syndrome (SIRS), or cannot tolerate oral medications or have compliance concerns 2
Vancomycin 15-20 mg/kg IV every 8-12 hours is first-line therapy for hospitalized patients, with alternatives including linezolid 600 mg IV twice daily or daptomycin 4 mg/kg IV once daily 1, 2

Patients with non-purulent cellulitis who have failed cephalexin therapy should be treated for 5 days if clinical improvement occurs, with mandatory reassessment at 48-72 hours to verify clinical response 2

Elevating the affected leg above heart level for at least 30 minutes three times daily, examining interdigital toe spaces for tinea pedis, and addressing underlying venous insufficiency and lymphedema with compression stockings once acute infection resolves are critical non-antibiotic interventions 2

Continuing ineffective antibiotics beyond 48 hours, using TMP-SMX or doxycycline as monotherapy, assuming all treatment failures are MRSA, and delaying surgical consultation if signs of necrotizing infection are present should be avoided 1, 2